UCB recognised for cell research | UCB
UCB's Global Corporate Website

UCB recognised for cell research

Posted by
Laurent Schots, Global Communications & Company Reputation
24-Jul-2015
A leading UCB researcher has received an award from a scientific society in recognition of his work on the development of cell culture biotechnologies.

Stefanos Grammatikos, Head of Biotech Services at UCB, was presented with the ESACT Medal for his leadership role in ESACT and his contribution to the promotion of the protein therapeutics industry in Europe.

Stefanos has developed technologies that accelerated the development and manufacture of monoclonal antibodies – modern biological medicines that can be used to treat autoimmune diseases.

ESACT is a Society which brings together scientists, engineers and other specialists working with cells. It was founded in 1976 to create a forum for the exchange of ideas on biological and engineering techniques.

Its membership consists of scientists and engineers in academic, medical and industrial R&D and production at applied science institutions and universities, in the medical services, in industry, and in the political and regulatory bodies.

Stefanos has been an active member of the Society and was an elected member of its Executive Committee from 2001 to 2013.

In paying tribute to Stefanos' achievements, Professor Terry Papoutsakis of the University of Delaware, acknowledged UCB's leadership position in pharma and biotech.

It is thanks to the stellar individual scientists like Stefanos that we have collectively succeeded in bringing new medicines to patients.

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.
14 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.